SGLT2 inhibitor dapagliflozin safe and effective in patients with advanced kidney disease: Study Hina Zahid21 July 2021 6:15 PM ISTThe effects of dapagliflozin in patients with stage 4 CKD are similar to effects in patients with mild to moderate CKD. USA: The benefits of...
FDA approves spinal cord stimulation device for patients with painful diabetic neuropathy Dr. Kamal Kant Kohli21 July 2021 6:00 PM ISTUSA: The Food and drugs administration has approved first spinal cord stimulation device (HFX) for painful diabetic neuropathy (PDN). The device is...
Intensive blood sugar control of no significant benefit for eye outcomes in Diabetes: Study Medha Baranwal21 July 2021 11:30 AM ISTUSA: Intensive glycemic control (INT) compared with standard glycemic control does not have a protective role in eye procedures and surgical events in...
Cycling lowers risk of premature mortality in diabetes patients: JAMA Medha Baranwal21 July 2021 9:30 AM ISTDenmark: Cycling is associated with a lower risk of all-cause and CVD mortality in diabetes patients independent of other types of physical activity,...
SGLT2 inhibitors improve survival over DPP4i in patients with cirrhosis and diabetes: Study Medha Baranwal20 July 2021 11:45 AM ISTPatients with cirrhosis needing additional pharmacotherapy for diabetes beyond metformin experience increased survival with SGLT2i in relation to...
Fermented foods can keep weight in check and prevent diabetes, CVD, and cancer: Study Hina Zahid20 July 2021 9:00 AM ISTHigh-fiber diets have been associated with lower rates of mortality, the consumption of fermented foods can help with weight maintenance and may...
Intraglomerular dysfunction may predict kidney failure in type 2 diabetes patients: Study Medha Baranwal20 July 2021 9:00 AM ISTUSA: Intraglomerular dysfunction can predict kidney failure in type 2 diabetes (T2D) patients, suggests a recent study in Diabetes, the journal of the...
Diabetes: Study suggests SGLT2 inhibitors role in primary prevention of diabetic kidney disease Medha Baranwal19 July 2021 10:48 AM ISTDelhi: Dapagliflozin, an SGLT2 inhibitor, may be used for the primary prevention of diabetic kidney disease, suggests recent results from DECLARE-TIMI...
Liraglutide addition to SGLT2 inhibitors intensifies type 2 diabetes treatment: Study Medha Baranwal17 July 2021 12:45 PM ISTDelhi: Liraglutide (1.8 mg) seems to be an effective way to intensify the treatment of type 2 diabetes irrespective of BMI, HbA1c, insulin resistance,...
High dose of steroids in severe COVID-19 tied to Thyroid dysfunction: PGIMER Study Dr. Shravani Dali16 July 2021 11:30 AM ISTSpecialists at the department of endocrinology, PGIMER, have found that patients with acute Covid-19 infection get more frequent and severe thyroid...
SGLT-2 Inhibitors Increase Retinal Vein Occlusion Risk in Diabetics, Study Finds MD Bureau16 July 2021 9:00 AM ISTSGLT2 inhibitors are associated with an increased risk of RVO when compared with other glucose lowering drugs.
Sotagliflozin use linked to reduced risk of heart attack, heart failure and stroke in diabetics: Study Medha Baranwal15 July 2021 9:00 AM ISTSotagliflozin is not FDA approved and if it is brought to the market, it would signify a major advance in the care of patients with diabetes,...
